PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
基本信息
- 批准号:10674471
- 负责人:
- 金额:$ 29.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:Atypical Endometrial HyperplasiasAtypical hyperplasiaComplexContractorDiagnosisEndometrialEndometrial CarcinomaEndometrial HyperplasiaEndometrial Intraepithelial NeoplasiaExemestaneIntraepithelial NeoplasiaMeasuresOperative Surgical ProceduresPilot ProjectsPostmenopauseS-Phase FractionTissuesWomancancer cell
项目摘要
The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.
承包商将进行一项术前试点研究,以评价每日服用维司坦对诊断为复杂非典型增生/子宫内膜上皮内瘤变或1级子宫内膜癌的绝经后妇女子宫内膜组织增殖的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD BAILEY其他文献
HOWARD BAILEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD BAILEY', 18)}}的其他基金
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10425188 - 财政年份:2021
- 资助金额:
$ 29.66万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10683047 - 财政年份:2021
- 资助金额:
$ 29.66万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10045662 - 财政年份:2019
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10020284 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
IGF::OT::IGF 对患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
9575740 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10222480 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10458433 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
IGF::OT::IGF - CORE INFRASTRUCTURE SUPPORT
IGF::OT::IGF - 核心基础设施支持
- 批准号:
9553428 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
IGF::OT::IGF PHASE IB 9CUAB30 IN EARLY STAGE BREAST CANCER TO EVALUATE BIOLOGIC EFFECT
IGF::OT::IGF IB 9CUAB30 期在早期乳腺癌中评估生物学效应
- 批准号:
9369074 - 财政年份:2016
- 资助金额:
$ 29.66万 - 项目类别:
PHASE IB 9CUAB30 IN EARLY STAGE BREAST CANCER TO EVALUATE BIOLOGIC EFFECT
IB 期 9CUAB30 在早期乳腺癌中评估生物学效应
- 批准号:
10249044 - 财政年份:2016
- 资助金额:
$ 29.66万 - 项目类别:
相似海外基金
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
生物标志物可提高非典型增生女性乳腺癌预防的针对性
- 批准号:
10542756 - 财政年份:2020
- 资助金额:
$ 29.66万 - 项目类别:
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
生物标志物可提高非典型增生女性乳腺癌预防的针对性
- 批准号:
9884497 - 财政年份:2020
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10020284 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
IGF::OT::IGF 对患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
9575740 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10222480 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
- 批准号:
10458433 - 财政年份:2017
- 资助金额:
$ 29.66万 - 项目类别:
P1: Novel Targeted Strategies for Prevention and Conservative Management of Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Cancer
P1:复杂非典型增生和 1 级子宫内膜样子宫内膜癌的预防和保守治疗的新靶向策略
- 批准号:
10006203 - 财政年份:2003
- 资助金额:
$ 29.66万 - 项目类别:
P1: Novel Targeted Strategies for Prevention and Conservative Management of Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Cancer
P1:复杂非典型增生和 1 级子宫内膜样子宫内膜癌的预防和保守治疗的新靶向策略
- 批准号:
9763468 - 财政年份:
- 资助金额:
$ 29.66万 - 项目类别: